Efficacy of memantine in patients with moderate-to-severe Alzheimer's disease: results of pooled analysis, using realistic definitions of response, of two randomized, double-blind, placebo-controlled trials in Japa
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000026013
- Lead Sponsor
- Daiichi Sankyo Co., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 633
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not have a result of efficacy assessment at the start of the study
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients showing clinical worsening in individual domains, and in combined multiple domains. Domains are as follows: - SIB-J (cognition) - CIBIC plus-J (Global ststus) - FAST (Function) - Behave-AD (BPSD)
- Secondary Outcome Measures
Name Time Method